secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2023-11-03T23:59:59+00:00
Accession:  0001628908-23-000169
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent files audited 2022 financials of acquired Magellan Specialty Health
---------------------------------------------------------------------------

- Magellan Specialty Health reported 2022 net revenue of $255.3M and net income of $42.3M.
- Total assets as of Dec 31, 2022 were $161.8M, including $113.2M of goodwill.
- Acquisition closed Jan 20, 2023; pro forma combined info for year-end 2022 and 9M 2023 also furnished.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000169/0001628908-23-000169-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000169/evh-20231102.htm
  HTML page:      https://secwatch.observer/filing/0001628908-23-000169

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer